Testing the Effect of a Warning About New Drugs
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 2,944
- 主要终点
- Hypothetical choice of old (vs. newer) drug
研究概览
简要总结
The purpose of this study is to test whether a new drug warning decreases enthusiasm for new drugs.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 盲法
- Single (Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Participants will be randomly selected from a research panel of more than 60,000 U.S. households (Knowledge Networks).
排除标准
- 未提供
研究组 & 干预措施
Directive new drug warning
Survey contains information about when the drug was approved by the FDA (2009)and a directive warning (i.e., stating the issue and why it matters) for new drugs.
This directive warning mentions that serious drug side effects may emerge only after the drug is already on the market, and the reader should ask their doctor there is an available drug with a longer track record.
干预措施: Presentation of information about drug approval and level of warning (Other)
Non-directive new drug warning
Survey contains information about when the drug was approved by the FDA (2009) and a non-directive warning (i.e., just stating the issue) for new drugs.
This non-directive warning mentions only that serious drug side effects may emerge only after the drug is already on the market.
干预措施: Presentation of information about drug approval and level of warning (Other)
No new drug warning
Survey contains information about when the drug was approved by the FDA (2009) only.
干预措施: Presentation of information about drug approval and level of warning (Other)
结局指标
主要结局
Hypothetical choice of old (vs. newer) drug
时间窗: 0 weeks (assessed during intervention)
次要结局
- Comprehension of the drug warning and drug information(0 weeks (assessed during intervention))